KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Edwards Lifesciences (EW) Income from Continuing Operations (2016 - 2025)

Historic Income from Continuing Operations for Edwards Lifesciences (EW) over the last 17 years, with Q3 2025 value amounting to $292.3 million.

  • Edwards Lifesciences' Income from Continuing Operations fell 1927.64% to $292.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year decrease of 341.74%. This contributed to the annual value of $1.4 billion for FY2024, which is 1442.62% up from last year.
  • According to the latest figures from Q3 2025, Edwards Lifesciences' Income from Continuing Operations is $292.3 million, which was down 1927.64% from $335.9 million recorded in Q2 2025.
  • Edwards Lifesciences' 5-year Income from Continuing Operations high stood at $489.5 million for Q2 2021, and its period low was $200.5 million during Q4 2022.
  • In the last 5 years, Edwards Lifesciences' Income from Continuing Operations had a median value of $340.1 million in 2021 and averaged $340.9 million.
  • As far as peak fluctuations go, Edwards Lifesciences' Income from Continuing Operations surged by 50155.87% in 2021, and later plummeted by 4020.28% in 2022.
  • Quarter analysis of 5 years shows Edwards Lifesciences' Income from Continuing Operations stood at $335.3 million in 2021, then plummeted by 40.2% to $200.5 million in 2022, then surged by 66.13% to $333.1 million in 2023, then grew by 3.57% to $345.0 million in 2024, then dropped by 15.28% to $292.3 million in 2025.
  • Its Income from Continuing Operations stands at $292.3 million for Q3 2025, versus $335.9 million for Q2 2025 and $363.6 million for Q1 2025.